Certain glycol ethers
Certain glycol ethers releases at Mazda Toyota Manufacturing USA INC. rose from 133k lb to 205k lb between 2023 and 2024.
Total reported releases 227k lb fell modestly year over year (-12%). Total releases concentrations have more than doubled since 2021.
9000 GREENBRIER PARKWAY NW, Madison, Alabama · 336110 · Transportation Equipment
Certain glycol ethers releases at Mazda Toyota Manufacturing USA INC. rose from 133k lb to 205k lb between 2023 and 2024.
1,2,4-Trimethylbenzene releases at Mazda Toyota Manufacturing USA INC. fell from 73k lb to 10k lb (86% lower) between 2023 and 2024.
n-Butyl alcohol releases at Mazda Toyota Manufacturing USA INC. fell from 28k lb to 4k lb (84% lower) between 2023 and 2024.
Certain glycol ethers concentrations have more than doubled since 2021.
1,2,4-Trimethylbenzene concentrations have fallen 42% since 2021.
n-Butyl alcohol concentrations have fallen 35% since 2021.
Methyl isobutyl ketone concentrations have fallen 31% since 2021.
Xylene (mixed isomers) concentrations have fallen 18% since 2021.
Toluene concentrations have more than doubled since 2021.
Methanol concentrations have more than doubled since 2021.
Ethylbenzene concentrations are roughly unchanged from 2023.
Within 3 miles of this facility (1 Census block groups, population-weighted demographics): a population of 2,533. Why we surface this →
Low-income
People of color
Under age 5
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.